VCAM-1/α4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disorders
Open Access
- 1 December 1996
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 98 (6) , S270-S277
- https://doi.org/10.1016/s0091-6749(96)70075-1
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- The 3D‐structure of a natural inhibitor of cell adhesion molecule expressionFEBS Letters, 1996
- Interleukin‐4 induces endothelial vascular cell adhesion molecule‐1 (VCAM‐1) by an NF‐κb‐independent mechanismFEBS Letters, 1995
- Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell ActivationBiochemical and Biophysical Research Communications, 1995
- Recruitment of lymphocytes during cutaneous delayed hypersensitivity in nonhuman primates is dependent on E-selectin and vascular cell adhesion molecule 1.Journal of Clinical Investigation, 1994
- CC chemokines in allergic inflammationImmunology Today, 1994
- Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthmaJournal of Allergy and Clinical Immunology, 1993
- TREATMENT WITH ANTI-VASCULAR CELL ADHESION MOLECULE 1 MONOCLONAL ANTIBODY INDUCES LONG-TERM MURINE CARDIAC ALLOGRAFT ACCEPTANCETransplantation, 1993
- Vascular cell adhesion molecule—1: Expression in normal and diseased skin and regulation in vivo by interferon gammaJournal of the American Academy of Dermatology, 1993
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986